Horst Sievert, MD

Country Germany
Specialty Interventional Cardiologist
  1. Selected New LAA Closure Techniques and Devices
  2. Innovations in Transcatheter Tricuspid Valve Interventions: What is Coming?
  3. Current Status of TAVR - What We Have Achieved?
  4. The REDUCE-FMR Trial
  5. The Big Picture: Choosing the Right Device for the Right Anatomy
  6. REDUCE-FMR
  7. TAVR Outcome of Venus and Venibri Valves
  8. Complication During Mitral Valve Intervention
  9. Patient and Device Selection for ViV TAVR: The Good, the Bad, and the Ugly
  10. MV and TV Intervention: Current Status and Future Perspectives
  11. Severe Secondary MR: Medical Treatment vs. Surgery vs. Intervention
  12. Where to with Cerebral Protection in TAVI?
  13. Micromesh Technology in Carotid Stents: Soft vs. Hard Landing
  14. Transcatheter Tricuspid Valve Repair
  15. Carotid Artery Stenosis: Optimal Candidate for Revascularization
  16. [Invited Case Presentation & Focus Review] TAVI: That Should Not Be too Difficult.
  17. TAVR for Low Risk and Younger Patients
  18. Severe Asymptomatic Aortic Stenosis
  19. Initial Experience with a Bioresorbable ASD/PFO Occluder
  20. Current Procedural Recommendations of Renal Denervation in 2016
  21. Transcatheter Mitral Valve Replacement Beyond Repair: New Paradigm Changes or Not Yet?
  22. Renal Denervation and Treatment of Hypertension: Clinical Update
  23. Practical Question: How We Should Define \"Responsiveness\" to Renal Denervation - HTN and Beyond HTN Indications
  24. Should PFOs Be Closed?
  25. Clinical Data and Guidelines Update; From Clinical Trial to Real-world Registry
  26. Clinical Trials for PFO Closure: Lessons Learnt and Future Perspectives
  27. Challenging Anatomies and Situations
  28. Devices and Long-term Outcomes of Renal Denervation for Hypertension
  29. To Closure or Not to Closure(LAA Closure & PFO Closure)
  30. Place of LAAC in the Era of New OATs
  31. Transcatheter Renal Denervation Therapy: A Breakthrough for Refractory Hypertension?
  32. LAA Closure with the Watchman versus Amplatzer Cardiac Plug
  33. Acute and Chronic Complications in ASD Closure
  34. Which System Is better?: Watchman or Cardiac Plug or Something
  35. What We\'ve Learned from Simplicity HTN-1,2, and Registries
  36. Transcatheter Renal Denervation for Refractory Hypertension: Current Understanding and Future Projections
  37. Left Atrial Appendage Closure - State of the Art
  38. Percutaneous LAA Closure: A Future Management Alternative for Stroke Prevention in AF Patients
  39. New Directions- Structural Heart Disease Intervention
  40. Update on Percutaneous PFO Closure